Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)

BACKGROUND: Effective treatment options for inoperable, metastatic, or recurrent canine pheochromocytomas are lacking. In humans, specific germline mutations exist that drive the development of pheochromocytomas. Pharmaceutical blockade of these abnormalities with small molecule inhibitors are an ef...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Vet Res
Päätekijät: Musser, Margaret L., Taikowski, Kathryn L., Johannes, Chad M., Bergman, Philip J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122699/
https://ncbi.nlm.nih.gov/pubmed/30176869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-018-1597-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia